CleanCap® EPO mRNA (5moU) - (L-7209)
0
EPO mRNA encodes the human erythropoietin (EPO) protein, a hormone that controls erythropoiesis, or red blood cell production. EPO also plays a role in wound healing and the brain’s response to neural injury. Kariko et al. showed that transfection of EPO mRNA in vivo resulted in significant increases of both reticulocyte counts and hematocrits.
This mRNA is capped using CleanCap, TriLink's proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.
| Catalog No | L-7209 |
|---|---|
| Purity | Passes Agarose Gel Mobility |
| Length | 858 nucleotides |
| Base Composition | Fully substituted with 5-Methoxy-U |
| Concentration | 1.0 mg/mL |
| Buffer | 1 mM Sodium Citrate pH 6.4 |
| Conversion Factor | 40 µg/OD260 |
| Recommended Storage | At or below -40°C |
| Application | CRISPR, Reporter Genes |
| Other Name(s) | CleanCap®Erythropoietin mRNA (5-methoxyuridine) |
Ask an Expert
CoA search tool
CleanCap For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/cleancap-research-license. Patent or patent pending,see trilinkbiotech.com/legal-notices.
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
- Yanez Arteta, Marianna; Kjellman, Tomas; Bartesaghi, Stefano; Wallin, Simonetta; Wu, Xiaoqiu; Kvist, Alexander J.; Dabkowska, Aleksandra; Székely, Noémi; Radulescu, Aurel; Bergenholtz, Johan; Lindfors, Lennart . Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
- Jiang, Yuhang; Gaudin, Alice; Zhang, Junwei; Agarwal, Tushar; Song, Eric; Kauffman, Amy C.; Tietjen, Gregory T.; Wang, Yongheng; Jiang, Zhaozhong; Cheng, Christopher J.; Saltzman, W. Mark . A "top-down" approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery.
- De Scheerder, Louis; Sparén, Anders; Nilsson, Gunilla A.; Norrby, Per-Ola; Örnskov, Eivor . Designing flexible low-viscous sieving media for capillary electrophoresis analysis of ribonucleic acids.
- Dilliard, SA;Cheng, Q;Siegwart, DJ; . On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
- Fekete, S;Yang, H;Wyndham, K;Lauber, M; . Salt gradient and ion-pair mediated anion exchange of intact messenger ribonucleic acids
